HSS Shoulder Joint Replacement Registry

Institutional Review Board, Hospital for Special Surgery

October 05, 2007

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Robert Marx MD, MSc

Co-Investigators

Gina Aharonoff, MPH
Answorth A. Allen, MD
David W. Altchek, MD
Katie Belleisle, BS
Nadia Camille, BA
Struan H. Coleman, MD, PhD
Frank A. Cordasco, MD, MS
Edward V. Craig, MD, MPH
David M. Dines, MD
Huong Do, MS
Rhonda El-Sheikh, MS
Stephen Fealy, MD
Daniel Fischer, BA
Hassan Ghomrawi, PhD, MPH
Steven R. Goldring, MD
Patrick Grimm, BA
Jason Guardado
Tamara Hagoel, BA
Jo A. Hannafin, MD, PhD
Jonathan Kassak, BS, MBA
Bryan T. Kelly, MD
Anne M. Kelly, MD
Adrita Khan, BA
Stephen Lyman, PhD
John D. MacGillivray, MD
Lisa Mandl, MD, MPH
Robert G. Marx, MD, MSc, FRCSC
Michael J. Maynard, MD
Madhu Mazumdar, PhD, MA, MS
Alvin Mushlin, MD, Sc.M.
Stephen O’Brien, MD, MBA
Andrew D. Pearle, MD
Renee Razzano, M.A.
Laura Robbins, DSW, CSW, MSW
Scott A. Rodeo, MD
Howard Anthony Rose, MD
John Rutledge, M.A.S.
Thomas P. Sculco, MD
Justine Shum, AB
Beth Shubin Stein, MD
Russell F. Warren, MD
Andrew J. Weiland, MD
Thomas L. Wickiewicz, MD
Riley J. Williams III, MD

 

Summary

We will enroll all TSA patients who undergo surgery at HSS and consent to be in the study.  We estimate this to be approximately 200 patients a year.  Patients will receive follow-up questionnaires at one year, two years and five years after their surgery.

Inclusion/Exclusion Criteria

Patients 18 years or older undergoing total shoulder arthroplasty at HSS

Contact Information

Principal Investigator
Robert Marx MD, MSc
212.606.1645

Research Coordinator
Samuel Chu
212.606.1866